Oral cancer and precancerous lesions
BW Neville, TA Day - CA: a cancer journal for clinicians, 2002 - Wiley Online Library
Abstract In the United States, cancers of the oral cavity and oropharynx represent
approximately three percent of all malignancies in men and two percent of all malignancies …
approximately three percent of all malignancies in men and two percent of all malignancies …
Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay?
I Gómez, S Warnakulasuriya… - Oral …, 2010 - Wiley Online Library
Oral Diseases (2010) 16, 333–342 Worldwide, oral cancer has one of the lowest survival
rates and poor prognosis remains unaffected despite recent therapeutic advances …
rates and poor prognosis remains unaffected despite recent therapeutic advances …
Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer
WR McIlwain, AJ Sood, SA Nguyen… - … Otolaryngology–Head & …, 2014 - jamanetwork.com
Importance This study addresses the most common initial symptoms of oropharyngeal
squamous cell carcinoma (OPSCC) and investigates differences between human …
squamous cell carcinoma (OPSCC) and investigates differences between human …
Factors associated with diagnostic delay of oral squamous cell carcinoma
K Onizawa, K Nishihara, K Yamagata, H Yusa… - Oral oncology, 2003 - Elsevier
Shortening the diagnostic delay from the onset of symptoms to the final diagnosis leads to
early cancer detection and a reduced incidence of advanced cases. To analyze factors …
early cancer detection and a reduced incidence of advanced cases. To analyze factors …
Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals
LP Kowalski, EL Franco, H Torloni, AS Fava… - European Journal of …, 1994 - Elsevier
The risk of presenting with advanced stage vs. early stage disease was evaluated in a
prospective study of 336 consecutive patients with oral and oropharyngeal carcinomas …
prospective study of 336 consecutive patients with oral and oropharyngeal carcinomas …
Oral cancer prevalence, mortality, and costs in Medicaid and commercial insurance claims data
Background: This study compared prevalence, incidence, mortality rates, treatment costs,
and risk factors for oral and oropharyngeal cancer (OC/OPC) between two large United …
and risk factors for oral and oropharyngeal cancer (OC/OPC) between two large United …
Factors associated with delay in the diagnosis of oral cancer
W Pitiphat, SR Diehl, G Laskaris… - Journal of dental …, 2002 - journals.sagepub.com
Early detection and treatment improve the prognosis for oral cancer. Delays from the onset
of symptoms to clinical diagnosis are common. Our aim is to identify factors associated with …
of symptoms to clinical diagnosis are common. Our aim is to identify factors associated with …
The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma
SE Scott, EA Grunfeld, M McGurk - Oral oncology, 2005 - Elsevier
Approximately half of patients with oral cancer present with advanced lesions when five-year
survival rates are as low as 20%, however, diagnostic delay has repeatedly been found to …
survival rates are as low as 20%, however, diagnostic delay has repeatedly been found to …
Delay in the diagnosis of oral squamous cell carcinoma
J Wildt, T Bundgaard… - Clinical Otolaryngology & …, 1995 - Wiley Online Library
Delay in diagnosis was recorded prospectively in 167 patients with an oral squamous cell
carcinoma. The median total delay was 4 months of which two‐thirds was patient delay. The …
carcinoma. The median total delay was 4 months of which two‐thirds was patient delay. The …
Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck
AL Carvalho, J Pintos, NF Schlecht… - … –Head & Neck …, 2002 - jamanetwork.com
Objective To identify the predictive factors (with emphasis on diagnostic delay) associated
with the diagnosis of an advanced–clinical stage head and neck cancer. Design Cross …
with the diagnosis of an advanced–clinical stage head and neck cancer. Design Cross …